Prediction and recommendation by machine learning through repetitive internal validation for hepatic veno-occlusive disease/sinusoidal obstruction syndrome and early death after allogeneic hematopoietic cell transplantation

  • Seungjoon Lee
  • , Eunsaem Lee
  • , Sung Soo Park
  • , Min Sue Park
  • , Jaewoo Jung
  • , Gi June Min
  • , Silvia Park
  • , Sung Eun Lee
  • , Byung Sik Cho
  • , Ki Seong Eom
  • , Yoo Jin Kim
  • , Seok Lee
  • , Hee Je Kim
  • , Chang Ki Min
  • , Seok Goo Cho
  • , Jong Wook Lee
  • , Hyung Ju Hwang
  • , Jae Ho Yoon

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Using traditional statistical methods, we previously analyzed the risk factors and treatment outcomes of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after allogeneic hematopoietic cell transplantation. Within the same cohort, we applied machine learning to create prediction and recommendation models. We analyzed 2572 transplants using eXtreme Gradient Boosting (XGBoost) to predict post-transplant VOD/SOS and early death. Using the XGBoost and SHapley Additive exPlanations (SHAP), we found influential factors and devised recommendation models, which were internally verified by repetitive ten-fold cross-validation. SHAP values suggested that gender, busulfan dosage, age, forced expiratory volume, and Disease Risk Index were significant factors for VOD/SOS. The areas under the receiver operating characteristic curves and the areas under the precision-recall curve of the models were 0.740, 0.144 for all VOD/SOS, 0.793, 0.793 for severe to very severe VOD/SOS, and 0.746, 0.304 for early death. According to our single feature recommendation, following the busulfan dosage was the most effective for preventing VOD/SOS. The recommendation method for six adjustable feature sets was also validated, and a subgroup corresponding to five to six features showed significant preventive power for VOD/SOS and early death. Our personalized treatment set recommendation showed reproducibility in repetitive internal validation, but large external cohorts should prospectively validate our model.

Original languageEnglish
Pages (from-to)538-546
Number of pages9
JournalBone Marrow Transplantation
Volume57
Issue number4
DOIs
StatePublished - Apr 2022

Bibliographical note

Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Nature Limited.

Fingerprint

Dive into the research topics of 'Prediction and recommendation by machine learning through repetitive internal validation for hepatic veno-occlusive disease/sinusoidal obstruction syndrome and early death after allogeneic hematopoietic cell transplantation'. Together they form a unique fingerprint.

Cite this